2001 to 2020 Saw Shift in Rx for Disease-Modifying Therapy for Multiple Sclerosis

THURSDAY, July 27, 2023 -- Oral disease-modifying therapies (DMTs) predominated new initiations for treatment of multiple sclerosis (MS) in 2020, according to a study published online July 10 in JAMA Neurology. Mackenzie Henderson, Pharm.D., from...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news